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Abstract 
Introduction: We present a case of adult onset Radiation-Induced Meningioma (RIM) following 
resection of astrocytoma with short latency period of only 18 months.  
Case Report: A 44-year old man who had high dose irradiation following astrocytoma resection came to 
our institution due to the appearance of intracranial tumor in the field of radiation in the follow-up MRI. 
Observation was done and a head CT scan was done 6 months later, where intracranial tumor was 
doubled in size. Surgical resection was done and histopathological result of high-grade meningioma 
confirming the diagnosis of RIM. Most RIM are usually presenting in children receiving high dose 
radiotherapy with mean latency period of 26.2 ± 9.3 years.  
Result: Our patient is older at presentation; he underwent astrocytoma resection previously and was 
receiving high dose irradiation of 46 Gy.  
Conclusion: In astrocytoma patients receiving adjuvant radiotherapy, physician must be aware of RIM; in 
addition to the recurrence of the high-grade gliomas.  
 




Radiotherapy has been used as therapeutic tools for many pathologies, however 
several evidence have reported an association between radiotherapy and the occurrence 
of secondary tumors.[1] In a longitudinal study by Vincon et al., 42 out of 552 children 
(7.2%) who received cranial irradiation developed radiation-induced tumor, with 
cumulative risks after 5 years and 10 years were 1.0% and 8.9% respectively. [2] 
Meningiomas has been found to be the most common radiation-induced tumor after 
brain irradiation. [1][3] Radiation-induced meningioma (RIM) has been largely 
documented in patients who received irradiation in their childhood. [4] A study 
conducted by Ron et al. showed that pediatric patient who received low dose irradiation 
(1-2 Gy) had a 9.5-fold risk of developing RIM. [5] The mean latency time from 
primary malignancy to the meningioma diagnosis was 26.2 ± 9.3 years. [3] Meanwhile, 
cases on short latency period for RIM were very scarce, where the shortest latency 
reported was 7 months. [6] The latency period is related to the age at irradiation, and 
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directly proportional with the secondary tumor's aggressiveness. [7][8][9] The pediatric 
population has a higher chance of developing RIM since their developing meninges is 
particularly sensitive to irradiation. [9]  
Widely defined criteria of the radiation induced brain tumor are as follows: 1) 
tumor occurred in the irradiated area; 2) sufficient latency period (i.e., usually >5 
years); 3) radiotherapy-induced tumor has different histological type than the primary 
neoplasm; 4) patient do not have pathologies favoring development of the tumor. [10] 
[11] [12] RIM has been classified into three groups based on the irradiation dosage: (1) 
low-dose (<10 Gy); (2) moderate dose (10-20 Gy) and (3) high dose (>20 Gy). [12] In 
this report, we present a case of 44-year-old man with short latency radiation-induced 
meningioma following high dose irradiation. 
Case Report 
A 40-year-old man went to Karyadi Hospital in October 2015 due to the bulging 
mass behind his right eye. He was unable to see from his right eye and complaining of 
persistent headache. The physical examination showed he had proptosis and optic nerve 
atrophy in the right eye. A head CT scan with contrast revealed a contrast-enhancing 
mass in the temporal region, behind the right eye, extending through the orbital wall and 
pushing the right eyeball (Figure 1). The mass was caseating in the centre, with an ill-
defined border. Eyeball exenteration and tumor biopsy were conducted. The 
pathological anatomy result showed proliferation of meningeal cells arranged 
hypercellular, with pleomorphic and hyperchromatic nuclei, 5 to 10 mitosis in high 
power field; consistent with pathological findings of atypical meningioma (WHO Grade 
II).  
 
Figure 1. Head CT  Scan showed a contrast enhancing mass behind the right eye, 
extending through the right temporal lobe. The size is 9 cm x 4.5 cm x 5 cm, with 
significant mass effect and minimal midline shift. 
Fourteen months after the first surgery in December 2016, the patient had fat-
like tissue coming out from the right orbit. The patient thus was referred to Soedjono 
Hospital. A pre-operative head CT scan was done in Soedjono Hospital, and contrast 
enhancing large intracranial mass in the right temporal lobe was found (Figure 2A.). 
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Surgery was planned to remove the intracranial mass. Intraoperatively, the tumor was 
found to be highly vascularized, and only part of the tumor was able to be resected.  A 
histopathological examination showed glial tumor cells consisting of rounded and oval 
cells with hyperchromatic nuclei; this finding was concluded as anaplastic astrocytoma 








Figure 2. CT Scan with contrast showed intracranial mass in the right temporal lobe 
with massive edema. Multiple hypodensities intratumorally was found. Profound 
midline shift can also be seen in this image (A). Histopathological findings with 
hematoxylin and eosin (HE) staining (x400) of the lesion showed rounded and oval glial 
cells which were hyperchromatic with moderate mitosis, concluded as anaplastic 
astrocytoma (B). 
Due to the patient's unstable condition, the irradiation was initiated in January 
2018, 18 months after the astrocytoma removal surgery. The irradiation given was 4,600 
cGy with booster up to 6,000 cGy in 4 weeks period. The patient was asymptomatic 
during the irradiation and underwent a close observation. No adjuvant chemotherapy 
was given to this patient. There was no tumor left in the right temporal lobe (Figure 3A, 
B.) 
Figure 3. Last T2 weighted 
MRI post irradiation. The 
intracranial mass was not 
found in the right temporal  




Since the patient wanted to get an artificial eyeball, he underwent a follow-up 
MRI in July 2019. MRI Scan was done, and a rounded homogenous contrast-enhancing 
intracranial mass was found (Figure 4A, B). He was then referred to Soedjono hospital 
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CT scan was done. The intracranial mass in the field of radiation increased in size to 4.2 
cm x 4.0 cm x 5 cm (Figure 4C, D). Surgical resection was performed, resulting in 
Simpson Grade IV (i.e., subtotal resection with a remaining mass in the base due to 
tumor's strong attachment to the surrounding tissue). A histopathological result showed 
proliferating rounded and oval cells with hyperchromatic and pleomorphic nuclei; 
mitosis was easily found with atypical tumor cells (Figure 5A, B). This finding was 
consistent with papillary meningioma (WHO grade III).   
Follow-up MRI two months after the surgery showed remaining mass in the 
right temporal base. A close observation and follow-up MRI 9 months later showed no 
progression, and the remaining mass appeared smaller. The patient had no complaints 
and agreed to do close monitoring.  
Figure 4. T1 weighted MRI 
with contrast 18 months after 
the last irradiation, a rounded 
homogenous and contrast        
enhancing intracranial mass 
was found, axial cut (A)  
sagittal cut (B). Pre-operative 
CT scan; pre contrast (C) and 
post contrast (D) showed 
rounded contrast enhancing 
lesion, homogenous, and well-
defined border mass in the 










Figure 5. Histopathological findings with HE staining  showed proliferation of rounded 
and oval pleomorphic cells, with hyperchromatic nucleus forming whorls formation. 
Tumor cells proliferation at the edge of the blood vessels creating a papillary structure 
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Discussion 
RIM is known as the most common secondary tumor caused by cranial 
irradiation. Radiation is able to induce meningeal reaction due to inflammatory 
adhesions between the brain and dura mater, stromal proliferation, and leptomeningeal 
thickening. [4] 
As previously mentioned, younger age at irradiation was found to be 
significantly correlated with the development of RIM. [13] A study conducted by 
Shuryak et al. hypothesized that many cases of RIM in childhood are due to process of 
initiation tumorigenesis (i.e., a process where mutations of normal stem cell shift the 
cells into a pre-malignant state; which potentially becomes fully malignant). [14] These 
pre-malignant cells in children have longer times to exploit their growth and have more 
rapid cellular proliferation rates. However, few documented cases explain the increased 
risks of RIM in older patients. [15] One possibility included promotion tumorigenesis; 
where irradiation increases the number of already existing pre-malignant cells; thus, 
increasing the acceleration of the cell's proliferation.[16] A case report by Hu et al 
described that short latency period in an adult can be caused by the presence of brain 
tumor stem cell (BTSC). This can be identified by using CD133+ marker, since it can 
exhibit stem cell properties in vitro and capable for initiating tumor in vivo. [6] These 
mechanisms may explain the incidence of short-latency RIM in our middle age patient.  
Our patient received 46 Gy of irradiation dose, which was classified as high dose 
irradiation.[12] This was one of the documented risk factors for RIM development, 
since the higher dose of radiation caused more rapid loss of cellular control mechanism 
and earlier expression of neoplastic phenotype. [11][17] The average latency period of 
high dose irradiation was 19.5 years compared with 35.2 years after low dose 
irradiation. [18]  
In radiation therapy, tumorigenesis was restricted to the normal cells that were 
not killed by radiation; eventually these cells mutated into neoplasia. [19] Therefore, the 
highest incidence of radiation-induced tumors occurs in the peripheries, where the 
tissues were exposed with a lower irradiation dose. [20] These findings were similar to 
our case, where the RIM occurred in the field with a lower irradiation dose.  
Several studies compared the characteristics of RIM with typical meningiomas. 
RIM was found to occur at an earlier age than spontaneous meningiomas, which usually 
occurred in the 5th or 6th decade of life), had a more aggressive nature, multiple, and 
higher recurrence after treatment. [21]  
Papillary meningioma (WHO Grade III) which was aggressive in our case was 
thought to be one of RIM characteristics after high dose irradiation. Higher proliferative 
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activity of high-grade tumor was associated with a shorter latency period of RIM. In a 
study conducted by Wilson et al., it was found that the more malignant the meningioma, 
the latency will be shorter. [22] Determination of mitotic labeling index also provides a 
dependable basis for planning further treatment for aggressive RIM.[9] 
The widely chosen approach in managing RIM is by completely removing the 
tumor surgically.[9][11] However, due to RIM's aggressive nature, difficult locations, 
and multiplicity, complete surgical removal is challenging to achieve. Due to its high 
recurrence, wider bone resection and more extensive dural margin excision are 
recommended.[18] Another challenge that needs to be addressed is that surgical 
approach through the previously irradiated field can lead to poor wound healing, CSF 
leakage, and a higher chance of infection. [11][12] Pre-operative investigation of RIM 
should be done more thoroughly since large-vessel occlusive vasculopathy is known to 
be one of the side effects of high dose irradiation. Adjunctive treatment for RIM 
following radical surgery was stereotactic radiosurgery, radiosurgery, and 
brachytherapy. Adjuvant chemotherapy or interferon management can also be one of the 
treatment options. [23]  
Several limitations in case management deserve mention. Firstly, we were 
unable to obtain the histopathological specimen from the first surgical procedure since 
the craniotomy was performed in a different hospital. Consequently, we could not re-
assess the pathological result from the previous hospital.  
RIM, which commonly presents in the adult who received cranial irradiation as a 
child, may hinder us from making a correct diagnosis in those receiving cranial 
irradiation as an adult. The possibility of RIM with short latency in adult prompt us to 
conduct a close regular follow up in patients receiving high dose cranial irradiation.   
 
Conclusion 
RIM has been known to be one of the consequences of radiotherapy and usually 
occurs in patients with a history of childhood radiotherapy. However, RIM which 
appears in adult receiving cranial irradiation is quite rare. Promotion tumorigenesis, 
where exposure to radiotherapy was causing increased proliferation of pre-existing 
malignant cells, might be the underlying pathomechanisms of this phenomenon, and 
high dose irradiation was one of the risk factors for the development of RIM. Therefore, 
regular follow-up should be warranted in an adult patient who received cranial 
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